T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVC
1626
Service Properties Trust
SVC
$1.06B
| $1.51M | ﹤0.01% |
9,194
| – | – |
|
1627
Zebra Technologies
ZBRA
$18B
| $1.5M | ﹤0.01% |
16,592
+206
| +1% | +$17.8K |
|
1628
AGCO
AGCO
$6.96B
| $1.5M | ﹤0.01% |
31,550
| – | – |
|
1629
The Greenbrier Companies
GBX
$1.42B
| $1.5M | ﹤0.01% |
25,900
+1,300
| +5% | +$71.8K |
|
1630
NCR Voyix
VYX
$1.17B
| $1.5M | ﹤0.01% |
82,708
+668
| +0.8% | +$11.6K |
|
|
BRSL
1631
Brightstar Lottery PLC
BRSL
$2.15B
| $1.49M | ﹤0.01% |
85,760
+1,290
| +2% | +$22.4K |
|
1632
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $1.48M | ﹤0.01% |
41,150
+13,800
| +50% | +$507K |
|
1633
Spire
SR
$4.9B
| $1.47M | ﹤0.01% |
28,710
+5,800
| +25% | +$304K |
|
1634
Liberty Broadband Class C
LBRDK
$5.29B
| $1.47M | ﹤0.01% |
25,955
+4,680
| +22% | +$237K |
|
|
DFRG
1635
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $1.45M | ﹤0.01% |
71,900
+22,200
| +45% | +$447K |
|
1636
NNN REIT
NNN
$8.87B
| $1.45M | ﹤0.01% |
35,330
| – | – |
|
1637
Brown & Brown
BRO
$24B
| $1.44M | ﹤0.01% |
86,800
-15,890
| -15% | -$257K |
|
|
UN
1638
DELISTED
Unilever NV New York Registry Shares
UN
| $1.43M | ﹤0.01% |
34,349
| – | – |
|
|
HNT
1639
DELISTED
HEALTH NET INC
HNT
| $1.43M | ﹤0.01% |
23,630
| – | – |
|
1640
Jabil
JBL
$38.8B
| $1.41M | ﹤0.01% |
60,300
+14,900
| +33% | +$325K |
|
|
LPT
1641
DELISTED
Liberty Property Trust
LPT
| $1.4M | ﹤0.01% |
39,333
| – | – |
|
|
TWO
1642
Two Harbors Investment
TWO
$1.26B
| $1.4M | ﹤0.01% |
16,438
-1,049
| -6% | -$87K |
|
1643
W.R. Berkley
WRB
$26.2B
| $1.4M | ﹤0.01% |
93,180
+7,087
| +8% | +$105K |
|
|
AWH
1644
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $1.39M | ﹤0.01% |
34,500
-10,980
| -24% | -$435K |
|
|
VMW
1645
DELISTED
VMware, Inc
VMW
| $1.39M | ﹤0.01% |
16,900
-5,840,818
| -100% | -$478M |
|
1646
Herbalife
HLF
$1.28B
| $1.39M | ﹤0.01% |
64,800
+7,200
| +13% | +$123K |
|
1647
United Natural Foods
UNFI
$2.94B
| $1.37M | ﹤0.01% |
17,800
-4,037
| -18% | -$316K |
|
|
ITC
1648
DELISTED
ITC HOLDINGS CORP
ITC
| $1.37M | ﹤0.01% |
36,587
-1,613
| -4% | -$64K |
|
1649
Owens Corning
OC
$12.3B
| $1.36M | ﹤0.01% |
31,300
-1,900
| -6% | -$75.3K |
|
1650
Gaming and Leisure Properties
GLPI
$12.7B
| $1.35M | ﹤0.01% |
36,662
+2,000
| +6% | +$67.5K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.